Skip to Main Content
Don't have an account? Create Account
Don't have an account? Create Account

340B Drug Pricing Program Advocacy Update

Date: Wednesday, January 10, 2018

Time: 2:00 PM ET

America’s Essential Hospitals continues to fight to protect the 340B Drug Pricing Program, a crucial source of support for essential hospitals. Participants heard an overview of our recent advocacy activities and an update on our next steps. Speakers reviewed and explained the judicial ruling on the ongoing 340B litigation filed jointly with the American Hospital Association and Association of American Medical Colleges. Staff experts gave an update on congressional 340B activity, including legislation to impose a moratorium on the Centers for Medicare & Medicaid Services’ implementation of 340B program cuts and the new 340B PAUSE bill.


Beth Feldpush, DrPH
Senior Vice President, Policy and Advocacy
America’s Essential Hospitals

Amanda Walsh, JD
Senior Manager, Legislative Affairs
America’s Essential Hospitals

Sarah Mutinsky, JD
Washington Counsel,
America’s Essential Hospitals
Founding Senior Advisor,
Eyman Associates

Previous Next
Test Caption
Test Description goes like this